RNF20 and USP44 Regulate Stem Cell Differentiation by Modulating H2B Monoubiquitylation

Molecular Cell

Volumn 46, Issue 5, 2012, Pages 662-673

  Fuchs, Gilad ^a   Shema, Efrat ^a   Vesterman, Rita ^a   Kotler, Eran ^a   Wolchinsky, Zohar ^b   Wilder, Sylvia ^a   Golomb, Lior ^a   Pribluda, Ariel ^a   Zhang, Feng ^e   Haj Yahya, Mahmood ^f   Feldmesser, Ester ^a   Brik, Ashraf ^f   Yu, Xiaochun ^e   Hanna, Jacob ^a   Aberdam, Daniel ^b,c,d   Domany, Eytan ^a   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d INSERM   (France)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE USP44; HISTONE H2B; LYSINE; UBIQUITIN E3 LIGASE RNF20; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; GENETIC TRANSCRIPTION; HISTONE UBIQUITINATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE;

ANIMALS; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DOWN-REGULATION; EMBRYONIC STEM CELLS; ENDOPEPTIDASES; EPIGENESIS, GENETIC; HISTONES; HUMANS; MICE; MODELS, GENETIC; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84861968321     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.05.023     Document Type: Article

References (59)

1. Andrews P.W. Human teratocarcinomas. Biochim. Biophys. Acta 1988, 948:17-36.
2. Ang Y.S., Gaspar-Maia A., Lemischka I.R., Bernstein E. Stem cells and reprogramming: breaking the epigenetic barrier?. Trends Pharmacol. Sci. 2011, 32:394-401.
3. Azuara V., Perry P., Sauer S., Spivakov M., Jorgensen H.F., John R.M., Gouti M., Casanova M., Warnes G., Merkenschlager M., Fisher A.G. Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 2006, 8:532-538.
4. Ballman K.V., Grill D.E., Oberg A.L., Therneau T.M. Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics 2004, 20:2778-2786.
5. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
6. Bhaumik S.R., Smith E., Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 2007, 14:1008-1016.
7. Bonnet J., Romier C., Tora L., Devys D. Zinc-finger UBPs: regulators of deubiquitylation. Trends Biochem. Sci. 2008, 33:369-375.
8. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
9. Buszczak M., Paterno S., Spradling A.C. Drosophila stem cells share a common requirement for the histone H2B ubiquitin protease scrawny. Science 2009, 323:248-251.
10. Campos E.I., Reinberg D. Histones: annotating chromatin. Annu. Rev. Genet. 2009, 43:559-599.
11. Chernikova S.B., Razorenova O.V., Higgins J.P., Sishc B.J., Nicolau M., Dorth J.A., Chernikova D.A., Kwok S., Brooks J.D., Bailey S.M., et al. Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Res. 2012, 72:2111-2119.
12. Fierz B., Chatterjee C., McGinty R.K., Bar-Dagan M., Raleigh D.P., Muir T.W. Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nat. Chem. Biol. 2011, 7:113-119.
13. Fisher C.L., Fisher A.G. Chromatin states in pluripotent, differentiated, and reprogrammed cells. Curr. Opin. Genet. Dev. 2011, 21:140-146.
14. Gaillard H., Tous C., Botet J., Gonzalez-Aguilera C., Quintero M.J., Viladevall L., Garcia-Rubio M.L., Rodriguez-Gil A., Marin A., Arino J., et al. Genome-wide analysis of factors affecting transcription elongation and DNA repair: a new role for PAF and Ccr4-not in transcription-coupled repair. PLoS Genet. 2009, 5:e1000364. 10.1371/journal.pgen.1000364.
15. Gutekunst M., Oren M., Weilbacher A., Dengler M.A., Markwardt C., Thomale J., Aulitzky W.E., van der Kuip H. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. PLoS ONE 2011, 6:e19198. 10.1371/journal.pone.0019198.
16. Hahn M.A., Dickson K.A., Jackson S., Clarkson A., Gill A.J., Marsh D.J. The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Hum. Mol. Genet. 2012, 21:559-568.
17. Hawkins R.D., Hon G.C., Lee L.K., Ngo Q., Lister R., Pelizzola M., Edsall L.E., Kuan S., Luu Y., Klugman S., et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 2010, 6:479-491.
18. Henry K.W., Wyce A., Lo W.S., Duggan L.J., Emre N.C., Kao C.F., Pillus L., Shilatifard A., Osley M.A., Berger S.L. Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. Genes Dev. 2003, 17:2648-2663.
19. Joo H.Y., Zhai L., Yang C., Nie S., Erdjument-Bromage H., Tempst P., Chang C., Wang H. Regulation of cell cycle progression and gene expression by H2A deubiquitination. Nature 2007, 449:1068-1072.
20. Jung M., Peterson H., Chavez L., Kahlem P., Lehrach H., Vilo J., Adjaye J. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. PLoS ONE 2010, 5:e10709. 10.1371/journal.pone.0010709.
21. Karpiuk O., Najafova Z., Kramer F., Hennion M., Galonska C., König A., Snaidero N., Vogel T., Shchebet A., Begus-Nahrmann Y., et al. The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells. Mol. Cell 2012, 46:705-713. this issue.
22. Kim J., Hake S.B., Roeder R.G. The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions. Mol. Cell 2005, 20:759-770.
23. Kim J., Guermah M., McGinty R.K., Lee J.S., Tang Z., Milne T.A., Shilatifard A., Muir T.W., Roeder R.G. RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 2009, 137:459-471.
24. Kuroda M., Oikawa K., Yoshida K., Takeuchi A., Takeuchi M., Usui M., Umezawa A., Mukai K. Effects of 3-methylcholanthrene on the transcriptional activity and mRNA accumulation of the oncogene hWAPL. Cancer Lett. 2005, 221:21-28.
25. Lee J.S., Shukla A., Schneider J., Swanson S.K., Washburn M.P., Florens L., Bhaumik S.R., Shilatifard A. Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS. Cell 2007, 131:1084-1096.
26. Ma M.K., Heath C., Hair A., West A.G. Histone crosstalk directed by H2B ubiquitination is required for chromatin boundary integrity. PLoS Genet. 2011, 7:e1002175. 10.1371/journal.pgen.1002175.
27. Martin-Subero J.I., Esteller M. Profiling epigenetic alterations in disease. Adv. Exp. Med. Biol. 2011, 711:162-177.
28. Medawar A., Virolle T., Rostagno P., de la Forest-Divonne S., Gambaro K., Rouleau M., Aberdam D. DeltaNp63 is essential for epidermal commitment of embryonic stem cells. PLoS ONE 2008, 3:e3441. 10.1371/journal.pone.0003441.
29. Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat. Biotechnol. 2010, 28:1079-1088.
30. Melcer S., Meshorer E. Chromatin plasticity in pluripotent cells. Essays Biochem. 2010, 48:245-262.
31. Minsky N., Shema E., Field Y., Schuster M., Segal E., Oren M. Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat. Cell Biol. 2008, 10:483-488.
32. Moyal L., Lerenthal Y., Gana-Weisz M., Mass G., So S., Wang S.Y., Eppink B., Chung Y.M., Shalev G., Shema E., et al. Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol. Cell 2011, 41:529-542.
33. Nakamura K., Kato A., Kobayashi J., Yanagihara H., Sakamoto S., Oliveira D.V., Shimada M., Tauchi H., Suzuki H., Tashiro S., et al. Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. Mol. Cell 2011, 41:515-528.
34. Nicassio F., Corrado N., Vissers J.H., Areces L.B., Bergink S., Marteijn J.A., Geverts B., Houtsmuller A.B., Vermeulen W., Di Fiore P.P., Citterio E. Human USP3 is a chromatin modifier required for S phase progression and genome stability. Curr. Biol. 2007, 17:1972-1977.
35. Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D. Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 2006, 125:703-717.
36. Phelps E.D., Updike D.L., Bullen E.C., Grammas P., Howard E.W. Transcriptional and posttranscriptional regulation of angiopoietin-2 expression mediated by IGF and PDGF in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2006, 290:C352-C361.
37. Pirngruber J., Shchebet A., Schreiber L., Shema E., Minsky N., Chapman R.D., Eick D., Aylon Y., Oren M., Johnsen S.A. CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing. EMBO Rep. 2009, 10:894-900.
38. Prenzel T., Begus-Nahrmann Y., Kramer F., Hennion M., Hsu C., Gorsler T., Hintermair C., Eick D., Kremmer E., Simons M., et al. Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Cancer Res. 2011, 71:5739-5753.
39. Schmitz R.J., Tamada Y., Doyle M.R., Zhang X., Amasino R.M. Histone H2B deubiquitination is required for transcriptional activation of FLOWERING LOCUS C and for proper control of flowering in Arabidopsis. Plant Physiol. 2009, 149:1196-1204.
40. Schwartz C.M., Spivak C.E., Baker S.C., McDaniel T.K., Loring J.F., Nguyen C., Chrest F.J., Wersto R., Arenas E., Zeng X., et al. NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev. 2005, 14:517-534.
41. Shahhoseini M., Taei A., Mehrjardi N.Z., Salekdeh G.H., Baharvand H. Epigenetic analysis of human embryonic carcinoma cells during retinoic acid-induced neural differentiation. Biochem. Cell Biol. 2010, 88:527-538.
42. Shema E., Tirosh I., Aylon Y., Huang J., Ye C., Moskovits N., Raver-Shapira N., Minsky N., Pirngruber J., Tarcic G., et al. The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev. 2008, 22:2664-2676.
43. Shema E., Kim J., Roeder R.G., Oren M. RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Mol. Cell 2011, 42:477-488.
44. Sowa M.E., Bennett E.J., Gygi S.P., Harper J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403.
45. Stegmeier F., Rape M., Draviam V.M., Nalepa G., Sowa M.E., Ang X.L., McDonald E.R., Li M.Z., Hannon G.J., Sorger P.K., et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 2007, 446:876-881.
46. Sun Z.W., Allis C.D. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 2002, 418:104-108.
47. Suresh B., Ramakrishna S., Lee H.J., Choi J.H., Kim J.Y., Ahn W.S., Baek K.H. K48- and K63-linked polyubiquitination of deubiquitinating enzyme USP44. Cell Biol. Int. 2010, 34:799-808.
48. Thorne A.W., Sautiere P., Briand G., Crane-Robinson C. The structure of ubiquitinated histone H2B. EMBO J. 1987, 6:1005-1010.
49. Vethantham V., Yang Y., Bowman C., Asp P., Lee J.H., Skalnik D.G., Dynlacht B.D. Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 trimethylation during myogenic differentiation. Mol. Cell. Biol. 2012, 32:1044-1055.
50. Vitaliano-Prunier A., Babour A., Herissant L., Apponi L., Margaritis T., Holstege F.C., Corbett A.H., Gwizdek C., Dargemont C. H2B ubiquitylation controls the formation of export-competent mRNP. Mol. Cell 2012, 45:132-139.
51. Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y. The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation. Mol. Cell 2011, 43:132-144.
52. Ying Q.L., Stavridis M., Griffiths D., Li M., Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 2003, 21:183-186.
53. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
54. Zeisel A., Amir A., Kostler W.J., Domany E. Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes. BMC Bioinformatics 2010, 11:400. 10.1186/1471-2105-11-400.
55. Zhang F., Yu X. WAC, a functional partner of RNF20/40, regulates histone H2B ubiquitination and gene transcription. Mol. Cell 2011, 41:384-397.
56. Zhang X.Y., Varthi M., Sykes S.M., Phillips C., Warzecha C., Zhu W., Wyce A., Thorne A.W., Berger S.L., McMahon S.B. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol. Cell 2008, 29:102-111.
57. Zhang Y., van Deursen J., Galardy P.J. Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia. PLoS ONE 2011, 6:e23389. 10.1371/journal.pone.0023389.
58. Zhu B., Zheng Y., Pham A.D., Mandal S.S., Erdjument-Bromage H., Tempst P., Reinberg D. Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Mol. Cell 2005, 20:601-611.
59. Zimmermann C., Chymkowitch P., Eldholm V., Putnam C.D., Lindvall J.M., Omerzu M., Bjoras M., Kolodner R.D., Enserink J.M. A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 links ubiquitin and Rad6-Bre1 to cell cycle progression. Proc. Natl. Acad. Sci. USA 2011, 108:18748-18753.